Health Med
By activating GLP-1 receptors, tirzepatide decelerates gastric emptying and reduces hunger signals, assisting in controlling blood sugar levels via insulin release when needed
Suspected adverse reactions to Rybelsus, including gallbladder problems, should be reported via the MHRA Yellow Card Scheme
This is because Mounjaro is not just a GLP-1 agonist because also contains a GIP agonist, having dual action in mimicking two key hormones involved in the regulation of insulin release and appetite
Mechanisms Under Investigation Current scientific literature describes Retatrutide as a peptide designed to activate GLP-1, GIP, and glucagon receptors
IP valuation framework: The NPV of Keytrudas patent portfolio at risk of biosimilar displacement is difficult to calculate precisely because of the extraordinary breadth of indication coverage, approximately 30 approved FDA indications